Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2006 | |
| Sales | 0 | 100 | 0 |
| Gross Profit | N/A | 100 | N/A |
| Operating Expenses | 5,379 | 1,531 | 0 |
| Operating Income | -5,379 | -1,431 | N/A |
| Interest Expense | 91 | 321 | 0 |
| Other Income | 200 | 339 | 0 |
| Pre-tax Income | -5,270 | -1,413 | 0 |
| Income Tax | N/A | -4 | N/A |
| Net Income Continuous | -5,270 | -1,409 | N/A |
| Net Income | $-5,270 | $-1,409 | $N/A |
| EPS Basic Total Ops | -78.40 | -32.00 | N/A |
| EPS Basic Continuous Ops | -45.53 | -12.55 | N/A |
| EPS Diluted Total Ops | -78.40 | -32.00 | N/A |
| EPS Diluted Continuous Ops | -45.53 | -12.55 | N/A |
| EBITDA(a) | $-5,369 | $-1,413 | $N/A |